Premium
Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Reporting extended results from phase III clinical trials
Author(s) -
Goodkin D. E.,
Reingold S.,
Sibley W.,
Wolinsky J.,
McFarland H.,
Cookfair D.,
Lublin F.
Publication year - 1999
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/1531-8249(199907)46:1<132::aid-ana22>3.0.co;2-z
Subject(s) - multiple sclerosis , clinical trial , medicine , library science , psychiatry , computer science